- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03326206
Evaluating the Navajo Community Outreach and Patient Empowerment (COPE) Program
Since 2009, a programmatic community-based strategy (COPE) has been implemented to address health disparities among Navajo individuals living with multiple chronic conditions. COPE (Community Outreach and Patient Empowerment) targets individual, family, and health system-level factors through four activities: 1) coordination between community health representatives (CHRs) and Indian Health Service providers; 2) CHR competency with standardized training; 3) a culturally-sensitive health promotion curriculum for patients and families; and 4) strong CHR supervision.
COPE has been implemented throughout Navajo Nation. Enrollment is programmatic; in other words, the decision to enroll a patient in COPE occurs independently of whether the patient is in this study. Participants receive the COPE intervention in the same manner and intensity, whether they are included in this observational study or not.
The main goal of this observational research is to understand if COPE improves the lives of participating community members. The Primary Aim is to assess the impact of the COPE Project on changes in HbA1c and other CVD risk factors. Hypothesis: Patients enrolled in the COPE program will experience a reduction in HbA1c compared to the control group. Secondary aims are: 1) To understand if COPE improves patients' own self-reported outcomes. Hypothesis: COPE patients will report better health compared with their own baseline at 12 months. 2) To Identify factors associated with increased effectiveness of the COPE Project at the individual, community, and health system level using a mixed-model approach. 3) To understand diverse stakeholder perspectives on COPE impact and value among CHRs, providers and the health care system. Hypothesis: Compared with baseline, CHRs will report greater empowerment in their work, providers will report greater confidence in CHRs.
The observational cohort will be comprised of individuals with diabetes receiving care at one of the participating health facilities. Cases include individuals participating in the COPE intervention; controls are non-COPE participants identified within the same hospital and matched based on similar baseline characteristics. Study findings will improve clinical and patient-decision making and the health of marginalized AI/ANs by informing policies to promote CHR interventions in rural and underserved communities.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study population: The study will take place on the Navajo Reservation and within Navajo Area IHS clinical facilities. The Navajo Reservation covers over 27,000 square miles in rural New Mexico and Arizona. The proposed evaluation will occur at the six sites, including two which are currently implementing COPE as well as four sites which will implement COPE in the next two years. The health care centers included in this evaluation represent a mix of federally and tribally operated programs and together provide care for over 200,000 individuals. All sites use a common suite of software applications to record electronic health care data: the IHS RPMS (Resource Patient Management System).
Study Design: The research is aligned with PCORI's definition of patient-centered research by answering questions that will allow patients and other stakeholders to make informed health care decisions. This will be completed by incorporating patient input at all stages; comparatively assessing the benefits and weaknesses of COPE; capturing the "voice" of stakeholders through qualitative methods; choosing outcomes that have been cited as relevant to patients' own priorities and decision-making; and studying cross-site variation to capture individual and community factors associated with impact. The study will address the following questions:
- Do clinical outcomes (hemoglobin A1c, blood pressure, cholesterol, and body mass index) improve more among COPE participants, compared with similar patients who do not participate in COPE?
- Do COPE patients experience improvements in self-rated overall health, quality of life, empowerment and satisfaction compared with similar patients who do not participate in COPE?
- As COPE is implemented in six different service units across the Navajo Nation, can we identify any factors among patients, CHRs, and hospitals that are "key ingredients" for COPE to be effective?
- Does COPE benefit the health system and population served from diverse stakeholder perspectives including CHRs, providers, and the local health care delivery system?
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Arizona
-
Chinle, Arizona, United States, 86503
- Chinle Comprehensive Health Care Facility
-
Fort Defiance, Arizona, United States, 86504
- Tsehootsooi Medical Center
-
Kayenta, Arizona, United States, 86033
- Kayenta Health Center
-
-
New Mexico
-
Crownpoint, New Mexico, United States, 87313
- Crownpoint Health Center Facility
-
Gallup, New Mexico, United States, 87301
- Gallup Indian Medical Center
-
Shiprock, New Mexico, United States, 87420
- Northern Navajo Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of diabetes
- Treated at a participating IHS facility corresponding to their home residence
Exclusion Criteria:
- Not seen in one of the six participating clinical sites
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
COPE participants
Individuals living with diabetes seen at a study site who were enrolled in the COPE programmatic intervention during the study period.
Participation in COPE consists of receiving home visits by a Navajo Community Health Representative (CHR) once or twice a month for a period of at least 12 months.
CHRs use structured patient coaching materials to support behavior change.
CHRs also check vital signs, monitor blood glucose levels through finger sticks, and facilitate access to appointments and medical refills.
CHRs communicate regularly with providers through electronic health record documentation and case management rounds.
In-person or telephone communication is be used to address acute issues that may arise.
|
The COPE Program is a programmatic model that is designed to support to providers, Community Health Representatives, and patients/family members.
Patients are referred to the COPE Program under program auspices.
COPE referral and participation is part of routine care at all service units in Navajo Area Indian Health Services, and enrollment is not influenced by study participation.
Patients receive the same health care services in the same manner and intensity, whether or not they are not enrolled in this observational study.
Other Names:
|
|
Non-COPE participants
Individuals living with diabetes seen at a study site, did not participate in the COPE programmatic intervention, and had comparable baseline characteristics.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Percentage of Glycated Hemoglobin (HbA1c)
Time Frame: 24 months
|
Change in Hemoglobin A1c measured at 24 months, compared with baseline
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Systolic Blood Pressure
Time Frame: 24 months
|
Changes in systolic blood pressure at 24 months, compared with baseline
|
24 months
|
|
Change in Low-density Lipoprotein
Time Frame: 24 months
|
Change in low density lipoprotein at 24 months, compared with baseline
|
24 months
|
|
Change in Body Mass Index
Time Frame: 24 months
|
change in body mass index at 24 months, compared with baseline
|
24 months
|
|
Change in Primary Outpatient Services
Time Frame: 24 months
|
Primary outpatient encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
It is notable that the clinic variable includes types of health utilization that are not limited to clinic visits, e.g.
inpatient, emergency primary, specialty, dental, counseling/behavioral care.
Each clinic visit reported in RPMS is counted as one utilization incident for the purposes of this analysis.
|
24 months
|
|
Change in Specialty Outpatient Services
Time Frame: 24 months
|
Specialty outpatient encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
It is notable that the clinic variable includes types of health utilization that are not limited to clinic visits, e.g.
inpatient, emergency primary, specialty, dental, counseling/behavioral care.
Each clinic visit reported in RPMS is counted as one utilization incident for the purposes of this analysis.
|
24 months
|
|
Change in Emergency Services
Time Frame: 24 months
|
Emergency encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
It is notable that the clinic variable includes types of health utilization that are not limited to clinic visits, e.g.
inpatient, emergency primary, specialty, dental, counseling/behavioral care.
Each clinic visit reported in RPMS is counted as one utilization incident for the purposes of this analysis.
|
24 months
|
|
Change in Counseling / Behavioral Services
Time Frame: 24 months
|
Counseling / behavioral encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
It is notable that the clinic variable includes types of health utilization that are not limited to clinic visits, e.g.
inpatient, emergency primary, specialty, dental, counseling/behavioral care.
Each "clinic visit" reported in RPMS is counted as one utilization incident for the purposes of this analysis.
|
24 months
|
|
Change in Laboratory Services
Time Frame: 24 months
|
Laboratory encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
It is notable that the clinic variable includes types of health utilization that are not limited to clinic visits, e.g.
inpatient, emergency primary, specialty, dental, counseling/behavioral care.
Each "clinic visit" reported in RPMS is counted as one utilization incident for the purposes of this analysis.
|
24 months
|
|
Change in Radiology Services
Time Frame: 24 months
|
Radiology encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
It is notable that the clinic variable includes types of health utilization that are not limited to clinic visits, e.g.
inpatient, emergency primary, specialty, dental, counseling/behavioral care.
Each "clinic visit" reported in RPMS is counted as one utilization incident for the purposes of this analysis.
|
24 months
|
|
Change in Pharmacy Services
Time Frame: 24 months
|
Pharmacy encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
It is notable that the clinic variable includes types of health utilization that are not limited to clinic visits, e.g.
inpatient, emergency primary, specialty, dental, counseling/behavioral care.
Each "clinic visit" reported in RPMS is counted as one utilization incident for the purposes of this analysis.
|
24 months
|
|
Change in Inpatient Services
Time Frame: 24 months
|
For inpatient services, the primary data point is the presence of a DRG code indicating the patient was hospitalized.
However, we also included clinic listings for labor and delivery and for observation as inpatient utilization.
|
24 months
|
|
Change in Dental Encounters
Time Frame: 24 months
|
Dental encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
It is notable that the clinic variable includes types of health utilization that are not limited to clinic visits, e.g.
inpatient, emergency primary, specialty, dental, counseling/behavioral care.
Each clinic visit reported in RPMS is counted as one utilization incident for the purposes of this analysis.
|
24 months
|
|
Change in Community Encounters
Time Frame: 24 months
|
Community encounters are identified using the Resource Patient Management System (RPMS) clinic variable.
Community Encounters may include public health nursing and community health representative visits; however, not all community encounters (e.g.
visits by Community Health Representatives in clinics where Community Health Representatives do not document their visits on the RPMS system) may be represented in this database
|
24 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient-reported Good Health
Time Frame: 12 months
|
Health status is assessed by three questions using a 5-point scale response to the General Health question from the Short Form 12 survey: "Would you say that in general your health is…" "Compared to your health a year ago, would you say your health is" and "Compared to other people your age, would you say your health is" (Excellent=5, Very Good=4, Good=3, Fair=2, Poor=1), where higher values are more favorable. Binary outcome of Good Health includes "Excellent," "Very good" and "Good" as yes, other responses as no. |
12 months
|
|
Patient-reported Sense of Control
Time Frame: 12 months
|
Sense of control is assessed using a 4-point scale response to the question "Do you feel you are in control of your health?" (Always Never=1, Rarely=2, Sometimes=3, Almost Always=4) with a higher value representing a favorable outcome.
Binary outcome derived by including "Almost Always" in "Yes" and "Always never," "Rarely" and "Sometimes" in "No"
|
12 months
|
|
Patient-reported Ability to Cope
Time Frame: 12 months
|
Coping will be assessed using a 4-point scale response to two questions "how often have you found that you couldn't cope with all the things that you had to do to?" (Always Never=4, Rarely=3, Sometimes=2, Almost Always=1) and "In the last month, how often have you been upset because of something that happened unexpectedly?"
(Always Never=4, Rarely=3, Sometimes=2, Almost Always=1) with a higher value representing a favorable outcome.
Binary variables derived by grouping "Always never" and "Rarely" as "Yes" and all others responses as "No"
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sonya S Shin, MD MPH, Brigham and Women's Hospital
Publications and helpful links
General Publications
- Franz C, Atwood S, Orav EJ, Curley C, Brown C, Trevisi L, Nelson AK, Begay MG, Shin S. Community-based outreach associated with increased health utilization among Navajo individuals living with diabetes: a matched cohort study. BMC Health Serv Res. 2020 May 25;20(1):460. doi: 10.1186/s12913-020-05231-4.
- Brown C, Lalla A, Curley C, King C, Muskett O, Salt S, Ray K, Begay MG, Nelson AK, Shin S. Community-clinic linkages: qualitative provider perspectives on partnering with community health representatives in Navajo Nation. BMJ Open. 2020 Feb 12;10(2):e031794. doi: 10.1136/bmjopen-2019-031794.
- Lalla A, Salt S, Schrier E, Brown C, Curley C, Muskett O, Begay MG, Shirley L, Clark C, Singer J, Shin S, Nelson AK. Qualitative evaluation of a community health representative program on patient experiences in Navajo Nation. BMC Health Serv Res. 2020 Jan 8;20(1):24. doi: 10.1186/s12913-019-4839-x.
- Trevisi L, Orav JE, Atwood S, Brown C, Curley C, King C, Muskett O, Sehn H, Nelson KA, Begay MG, Shin SS. Integrating community health representatives with health care systems: clinical outcomes among individuals with diabetes in Navajo Nation. Int J Equity Health. 2019 Nov 27;18(1):183. doi: 10.1186/s12939-019-1097-9.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Pathologic Processes
- Disease Attributes
- Metabolic Diseases
- Glucose Metabolism Disorders
- Insulin Resistance
- Hyperinsulinism
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Hypertension
- Metabolic Syndrome
- Diabetes Mellitus
- Chronic Disease
Other Study ID Numbers
- AD-1304-6566
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on COPE Program
-
Universidad Nacional de Educación a DistanciaIES Isaac NewtonCompletedDepressive Symptoms | Parental Stress | Anxiety SymptomsSpain
-
The University of Hong KongNot yet recruitingDepressive Symptoms | BPSD | Expressed Emotion
-
Matrouh UniversityAlexandria UniversityCompletedOutcome | Empowerment | Competence | InteractionEgypt
-
Temple UniversityCompleted
-
University of PittsburghCompletedAsthmaUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedAdvanced CancerUnited States
-
Ohio State UniversityUniversity of South Florida; New York University; National Institute on Minority... and other collaboratorsCompletedDepression | Anxiety | Emotional Disturbances | Nutritional Deficiency | Pregnancy Late | Post-Partum DepressionUnited States
-
National Taiwan University HospitalRecruitingEducation, MedicalTaiwan
-
Duke UniversityWithdrawnCancer | Cognitive ImpairmentUnited States
-
Ohio State UniversityAmerican Foundation for Suicide Prevention; University of San DiegoCompletedDepression | Burnout, Professional | Suicide ThreatUnited States